Yunnan Botanee Bio-Technology Group Co.LTD (SHE:300957)
China · Delayed Price · Currency is CNY 47.54
+0.10 (0.21%)
At close: Feb 6, 2026
SHE:300957 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 |
Net Income | 360.16 | 503.05 | 756.8 | 1,051 | 862.92 | 543.51 |
Depreciation & Amortization | 169.24 | 169.24 | 137.89 | 58.23 | 58.53 | 13.74 |
Other Amortization | 65.01 | 65.01 | 37.2 | - | 14.86 | 11.14 |
Loss (Gain) From Sale of Assets | 5.04 | 5.04 | -0.46 | - | -0.52 | 0.17 |
Asset Writedown & Restructuring Costs | 115.69 | 115.69 | - | - | 0.04 | 9.11 |
Loss (Gain) From Sale of Investments | -239.52 | -239.52 | -47.12 | - | -29.63 | -3.13 |
Provision & Write-off of Bad Debts | 12.4 | 12.4 | 12.97 | - | - | 5.47 |
Other Operating Activities | 648.28 | 69.94 | 29.6 | -340.12 | 17.24 | 1.58 |
Change in Accounts Receivable | -310.03 | -310.03 | -348.62 | - | -45.1 | -186.55 |
Change in Inventory | 254.89 | 254.89 | -121.42 | - | -221.43 | -51.69 |
Change in Accounts Payable | 92.5 | 92.5 | 162.54 | - | 490.74 | 90.62 |
Change in Other Net Operating Assets | - | - | - | - | 5.27 | - |
Operating Cash Flow | 1,130 | 694.87 | 610.44 | 769.45 | 1,153 | 431.03 |
Operating Cash Flow Growth | 129.55% | 13.83% | -20.66% | -33.25% | 167.44% | -16.29% |
Capital Expenditures | -561.66 | -378.38 | -274.28 | -353.42 | -270.68 | -89.45 |
Sale of Property, Plant & Equipment | 2.31 | 3.48 | 2.89 | 0.01 | 0.23 | 0 |
Cash Acquisitions | 0.01 | 0.01 | -493.5 | -7.47 | -6.5 | - |
Investment in Securities | 60.86 | -758.94 | 188.09 | 261.69 | -2,300 | - |
Other Investing Activities | 84.25 | 49.91 | 58.75 | 80.71 | 18.83 | 3.13 |
Investing Cash Flow | -414.22 | -1,084 | -518.06 | -18.49 | -2,558 | -86.32 |
Short-Term Debt Issued | - | - | - | - | - | 36.92 |
Long-Term Debt Issued | - | 837.71 | 105.45 | - | - | - |
Total Debt Issued | 586.48 | 837.71 | 105.45 | - | - | 36.92 |
Short-Term Debt Repaid | - | - | - | - | - | -51.86 |
Long-Term Debt Repaid | - | -388.87 | -100.64 | -64.72 | -42.89 | - |
Total Debt Repaid | -572.1 | -388.87 | -100.64 | -64.72 | -42.89 | -51.86 |
Net Debt Issued (Repaid) | 14.38 | 448.84 | 4.81 | -64.72 | -42.89 | -14.94 |
Issuance of Common Stock | - | - | - | - | 2,905 | - |
Repurchase of Common Stock | -124.88 | -124.88 | -109.84 | - | - | - |
Common Dividends Paid | -267.77 | -262.52 | -339.14 | -254.16 | -190.62 | -102.16 |
Other Financing Activities | 118.23 | -8.97 | -14.3 | -0.78 | -7.58 | -3.96 |
Financing Cash Flow | -260.04 | 52.47 | -458.47 | -319.66 | 2,664 | -121.05 |
Foreign Exchange Rate Adjustments | -5.27 | -1.23 | -0.72 | 0.03 | -0 | - |
Net Cash Flow | 450.78 | -337.82 | -366.81 | 431.32 | 1,258 | 223.66 |
Free Cash Flow | 568.66 | 316.48 | 336.16 | 416.02 | 882.04 | 341.57 |
Free Cash Flow Growth | 386.31% | -5.85% | -19.20% | -52.83% | 158.23% | -24.75% |
Free Cash Flow Margin | 10.97% | 5.52% | 5.87% | 8.30% | 21.93% | 12.96% |
Free Cash Flow Per Share | 1.34 | 0.76 | 0.80 | 0.98 | 2.17 | 0.95 |
Cash Income Tax Paid | 677.02 | 673.76 | 652.43 | 616.71 | 490.75 | 374.08 |
Levered Free Cash Flow | 589.91 | 98.54 | 70.03 | 30.36 | 612.5 | 217.25 |
Unlevered Free Cash Flow | 600.32 | 109.53 | 73.13 | 33.33 | 615.12 | 218.08 |
Change in Working Capital | -6 | -6 | -316.43 | - | 229.26 | -150.57 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.